Composite Warming Strategy Reduces Intraoperative Hypothermia in Open Hepatectomy for Liver Cancer
Condition(s) studied
Investigational drug(s) / intervention(s)
Compound heating strategy: After the surgery begins, a temperature monitoring device (disposable medical temperature sensor provided by the limited company) is inserted into the patient's nasopharynx to record the core temperature, while activating the water blanket and forced air heating system.
perioperative mandatory warming measures: perioperative mandatory warming measures
Study summary
The composite warming strategy has a certain effect on preventing hypothermia during cancer liver resection surgery. This study aims to explore the application of compound warming strategy in perioperative nursing of cancer liver resection.
This study will compare two groups: the control group using perioperative forced warming measures, and the experimental group using a composite warming strategy.
Main objective: Intraoperative temperature changes Secondary objective: incidence of complications The investigators' investigated the practicality and effectiveness of a combined warming strategy in open liver resection surgery. In addition, the investigators also conducted a quantitative correlation study on the incidence of hypothermia during the surgical process. This provides evidence-based guidance for the prevention of hypothermia during surgery.
Eligibility
Primary outcome measure(s)
- Intraoperative temperature changes — At the beginning of the surgery; every 5 minutes during surgery; after the surgery is completed.
Intraoperative temperature changes: After the surgery begins, a temperature monitoring device (disposable medical temperature sensor provided by the limited company) is inserted into the patient's nasopharynx to record the core temperature, while activating the water blanket and forced air.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| The First People's Hospital of Neijiang | Neijiang | Sichuan |
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT06766773 on ClinicalTrials.gov ↗ ← All trials in China